Amit Sachdev - Feb 16, 2024 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 16, 2024
Transactions value $
-$4,376,409
Form type
4
Date filed
2/21/2024, 04:38 PM
Previous filing
Feb 13, 2024
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$1.48M -3.5K -4.7% $424.01 70.9K Feb 16, 2024 Direct
transaction VRTX Common Stock Tax liability -$1.1M -2.62K -3.7% $420.58 68.2K Feb 20, 2024 Direct
transaction VRTX Common Stock Sale -$1.79M -4.25K -6.23% $420.79 64K Feb 20, 2024 Direct F1
holding VRTX Common Stock 882 Feb 16, 2024 401(k)
holding VRTX Common Stock 6.57K Feb 16, 2024 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.